Stem cell mutations in breast cancer may confer metastatic risk – The Oncology Report
|
Stem cell mutations in breast cancer may confer metastatic risk
The Oncology Report The likelihood of nodal metastases is increased in breast cancer patients whose tumors have breast cancer stem and progenitor cells with defects in PI3/Akt signaling. The findings, drawn from an analysis of surgical specimens, “support embarking on a … |
